Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP509668.RA-bZaKElGawbBagdNUD2T8Ma1lpbCyAq3wA-JbC55NmA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP509668.RA-bZaKElGawbBagdNUD2T8Ma1lpbCyAq3wA-JbC55NmA130_assertion type Assertion NP509668.RA-bZaKElGawbBagdNUD2T8Ma1lpbCyAq3wA-JbC55NmA130_head.
- NP509668.RA-bZaKElGawbBagdNUD2T8Ma1lpbCyAq3wA-JbC55NmA130_assertion description "[These findings indicate that downregulation of IDO controls ovarian cancer progression by activating NK cells, suggesting IDO targeting as a potential therapy for ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP509668.RA-bZaKElGawbBagdNUD2T8Ma1lpbCyAq3wA-JbC55NmA130_provenance.
- NP509668.RA-bZaKElGawbBagdNUD2T8Ma1lpbCyAq3wA-JbC55NmA130_assertion evidence source_evidence_literature NP509668.RA-bZaKElGawbBagdNUD2T8Ma1lpbCyAq3wA-JbC55NmA130_provenance.
- NP509668.RA-bZaKElGawbBagdNUD2T8Ma1lpbCyAq3wA-JbC55NmA130_assertion SIO_000772 22179492 NP509668.RA-bZaKElGawbBagdNUD2T8Ma1lpbCyAq3wA-JbC55NmA130_provenance.
- NP509668.RA-bZaKElGawbBagdNUD2T8Ma1lpbCyAq3wA-JbC55NmA130_assertion wasDerivedFrom befree-20150227 NP509668.RA-bZaKElGawbBagdNUD2T8Ma1lpbCyAq3wA-JbC55NmA130_provenance.
- NP509668.RA-bZaKElGawbBagdNUD2T8Ma1lpbCyAq3wA-JbC55NmA130_assertion wasGeneratedBy ECO_0000203 NP509668.RA-bZaKElGawbBagdNUD2T8Ma1lpbCyAq3wA-JbC55NmA130_provenance.